The REMOTE-ILD study is a 12-month, randomised clinical trial comparing remote monitoring vs. usual care in interstitial lung diseases. Clinical & health economics outcomes will be assessed.

Acceptability and feasibility of daily home spirometry for 3-months was demonstrated in a single-arm study in interstitial lung disease

Long-term home spirometry data is being captured via the patientMpower platform in the INJUSTIS observational study in interstitial lung disease. Interim analysis indicates acceptable levels of agreement with clinic spirometry.

The patientMpower platform was adopted by multiple healthcare providers in remote monitoring of COVID-19 during the pandemic. See peer-reviewed publications describing experience at Mater Hospital Dublin, St. Vincent's Hospital Dublin, Mount Sinai New York and multiple centres in Ireland are available. 

MobiHealth News article on patientMpower remote monitoring solution for COVID19